| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Marrow Diseases | 33 | 2022 | 234 | 7.820 |
Why?
|
| Exocrine Pancreatic Insufficiency | 16 | 2022 | 76 | 4.200 |
Why?
|
| Myelodysplastic Syndromes | 19 | 2022 | 1251 | 3.910 |
Why?
|
| Anemia, Aplastic | 13 | 2022 | 234 | 3.490 |
Why?
|
| Lipomatosis | 14 | 2020 | 107 | 3.450 |
Why?
|
| Germ-Line Mutation | 18 | 2022 | 1723 | 2.480 |
Why?
|
| Fanconi Anemia | 17 | 2022 | 319 | 2.460 |
Why?
|
| Leukemia | 7 | 2022 | 1514 | 1.520 |
Why?
|
| Neutropenia | 9 | 2022 | 877 | 1.450 |
Why?
|
| Anemia, Diamond-Blackfan | 10 | 2019 | 140 | 1.400 |
Why?
|
| Bone Marrow | 13 | 2022 | 2922 | 1.360 |
Why?
|
| Ribosomes | 7 | 2021 | 502 | 1.200 |
Why?
|
| Leukemia, Myeloid, Acute | 9 | 2022 | 3290 | 1.200 |
Why?
|
| Proto-Oncogene Proteins c-ets | 3 | 2017 | 317 | 1.190 |
Why?
|
| Genetic Diseases, Inborn | 7 | 2016 | 600 | 1.140 |
Why?
|
| Hematologic Neoplasms | 6 | 2022 | 1693 | 1.120 |
Why?
|
| Myeloproliferative Disorders | 5 | 2022 | 604 | 1.110 |
Why?
|
| Hematopoiesis | 11 | 2022 | 1989 | 0.960 |
Why?
|
| Proteins | 13 | 2020 | 6071 | 0.910 |
Why?
|
| Pancreatic Diseases | 3 | 2018 | 355 | 0.910 |
Why?
|
| Telomerase | 4 | 2022 | 734 | 0.830 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 2019 | 339 | 0.810 |
Why?
|
| Antilymphocyte Serum | 4 | 2019 | 518 | 0.800 |
Why?
|
| Genetic Testing | 5 | 2019 | 3347 | 0.790 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2022 | 17399 | 0.780 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2019 | 18 | 0.710 |
Why?
|
| Dyskeratosis Congenita | 7 | 2019 | 73 | 0.690 |
Why?
|
| Blood Platelet Disorders | 1 | 2019 | 59 | 0.680 |
Why?
|
| Cyclosporine | 2 | 2019 | 816 | 0.680 |
Why?
|
| Telomere | 3 | 2022 | 844 | 0.660 |
Why?
|
| Hematologic Diseases | 1 | 2022 | 489 | 0.660 |
Why?
|
| Pancreas, Exocrine | 2 | 2017 | 48 | 0.630 |
Why?
|
| Thrombocytopenia | 5 | 2019 | 1144 | 0.620 |
Why?
|
| Ikaros Transcription Factor | 1 | 2018 | 221 | 0.610 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 151 | 0.580 |
Why?
|
| Repressor Proteins | 3 | 2017 | 3064 | 0.570 |
Why?
|
| Metformin | 1 | 2022 | 805 | 0.560 |
Why?
|
| Mutation | 22 | 2022 | 29253 | 0.550 |
Why?
|
| Thrombopoietin | 1 | 2017 | 221 | 0.540 |
Why?
|
| Bone Marrow Transplantation | 4 | 2022 | 2763 | 0.520 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2022 | 5128 | 0.510 |
Why?
|
| Syndrome | 12 | 2022 | 3192 | 0.490 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2014 | 106 | 0.490 |
Why?
|
| GATA2 Transcription Factor | 3 | 2021 | 154 | 0.490 |
Why?
|
| Ribosome Subunits | 1 | 2012 | 3 | 0.480 |
Why?
|
| Child | 40 | 2022 | 74413 | 0.480 |
Why?
|
| Hematopoietic Stem Cells | 11 | 2022 | 3387 | 0.470 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2015 | 231 | 0.460 |
Why?
|
| Child, Preschool | 24 | 2022 | 41184 | 0.450 |
Why?
|
| Genomic Instability | 5 | 2016 | 687 | 0.440 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 1460 | 0.440 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 5 | 2018 | 148 | 0.410 |
Why?
|
| Pedigree | 10 | 2019 | 4704 | 0.400 |
Why?
|
| Infant | 22 | 2022 | 34561 | 0.390 |
Why?
|
| Humans | 110 | 2022 | 715594 | 0.380 |
Why?
|
| Lymphoma | 1 | 2019 | 1883 | 0.370 |
Why?
|
| Bone Marrow Cells | 5 | 2020 | 2560 | 0.350 |
Why?
|
| Chromosome Deletion | 4 | 2019 | 1372 | 0.340 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 2104 | 0.330 |
Why?
|
| Anemia, Sideroblastic | 2 | 2021 | 102 | 0.330 |
Why?
|
| Leukocyte Elastase | 2 | 2021 | 116 | 0.320 |
Why?
|
| Young Adult | 23 | 2022 | 56140 | 0.320 |
Why?
|
| Immunosuppressive Agents | 4 | 2020 | 4192 | 0.320 |
Why?
|
| RNA, Ribosomal | 2 | 2013 | 239 | 0.320 |
Why?
|
| Adolescent | 28 | 2022 | 85064 | 0.310 |
Why?
|
| Cell Cycle Proteins | 3 | 2016 | 3480 | 0.300 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3738 | 0.290 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2502 | 0.280 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2020 | 652 | 0.280 |
Why?
|
| Busulfan | 2 | 2017 | 271 | 0.270 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2021 | 371 | 0.270 |
Why?
|
| Disease Management | 3 | 2019 | 2520 | 0.270 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2822 | 0.260 |
Why?
|
| Phenotype | 10 | 2021 | 16302 | 0.260 |
Why?
|
| Cell Nucleolus | 1 | 2005 | 173 | 0.260 |
Why?
|
| Adult | 39 | 2022 | 212237 | 0.250 |
Why?
|
| Anemia, Macrocytic | 2 | 2016 | 56 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2019 | 331 | 0.240 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2017 | 635 | 0.240 |
Why?
|
| North America | 3 | 2021 | 1202 | 0.240 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2020 | 1589 | 0.230 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2022 | 22 | 0.230 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2022 | 85 | 0.220 |
Why?
|
| Female | 44 | 2021 | 377052 | 0.220 |
Why?
|
| Septins | 1 | 2021 | 51 | 0.220 |
Why?
|
| Male | 38 | 2021 | 350143 | 0.210 |
Why?
|
| Mutation, Missense | 3 | 2016 | 2515 | 0.210 |
Why?
|
| Siblings | 3 | 2016 | 823 | 0.210 |
Why?
|
| Chromosome Aberrations | 3 | 2019 | 1805 | 0.210 |
Why?
|
| Genomics | 3 | 2022 | 5338 | 0.210 |
Why?
|
| Blotting, Western | 2 | 2016 | 5369 | 0.210 |
Why?
|
| Genotype | 7 | 2021 | 12929 | 0.210 |
Why?
|
| Inflammation | 2 | 2020 | 10090 | 0.200 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.200 |
Why?
|
| Biology | 1 | 2022 | 200 | 0.200 |
Why?
|
| Karyotyping | 3 | 2019 | 1262 | 0.190 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2021 | 161 | 0.190 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2020 | 198 | 0.190 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2019 | 16 | 0.180 |
Why?
|
| Endocrine System | 1 | 2020 | 114 | 0.180 |
Why?
|
| Infant, Newborn | 10 | 2021 | 24776 | 0.180 |
Why?
|
| Family Health | 3 | 2017 | 1289 | 0.180 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 4966 | 0.180 |
Why?
|
| Smad2 Protein | 1 | 2019 | 165 | 0.180 |
Why?
|
| Ribosomal Proteins | 2 | 2016 | 354 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11238 | 0.170 |
Why?
|
| Transplantation Conditioning | 2 | 2017 | 1567 | 0.170 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4263 | 0.170 |
Why?
|
| Aeropyrum | 1 | 2017 | 4 | 0.170 |
Why?
|
| Protein Biosynthesis | 2 | 2017 | 2132 | 0.170 |
Why?
|
| Phosphorylation | 3 | 2019 | 8647 | 0.170 |
Why?
|
| Cells, Cultured | 10 | 2022 | 19892 | 0.170 |
Why?
|
| Signal Recognition Particle | 1 | 2017 | 44 | 0.170 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2019 | 120 | 0.160 |
Why?
|
| Inflammasomes | 1 | 2022 | 443 | 0.160 |
Why?
|
| Peroxiredoxins | 1 | 2017 | 50 | 0.160 |
Why?
|
| Eukaryotic Initiation Factors | 2 | 2021 | 94 | 0.160 |
Why?
|
| Galactosemias | 1 | 2019 | 137 | 0.160 |
Why?
|
| Pregnancy Complications, Hematologic | 2 | 2017 | 182 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2022 | 1116 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 3 | 2020 | 1973 | 0.160 |
Why?
|
| Cell Polarity | 1 | 2020 | 652 | 0.150 |
Why?
|
| Stromal Cells | 2 | 2012 | 1338 | 0.150 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2017 | 100 | 0.150 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 292 | 0.150 |
Why?
|
| Base Sequence | 3 | 2017 | 13171 | 0.150 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 2 | 2020 | 45 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2012 | 1702 | 0.150 |
Why?
|
| Prognosis | 7 | 2020 | 28991 | 0.150 |
Why?
|
| Neoplasms | 7 | 2022 | 20515 | 0.140 |
Why?
|
| Pancytopenia | 1 | 2016 | 105 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2016 | 220 | 0.140 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2022 | 1574 | 0.140 |
Why?
|
| Microtubules | 2 | 2014 | 1208 | 0.140 |
Why?
|
| Nuclear Proteins | 4 | 2013 | 5933 | 0.140 |
Why?
|
| Globins | 1 | 2016 | 431 | 0.140 |
Why?
|
| Cerebellar Ataxia | 1 | 2016 | 137 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2016 | 1120 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39334 | 0.130 |
Why?
|
| Megakaryocytes | 1 | 2019 | 533 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2017 | 2879 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4910 | 0.130 |
Why?
|
| BRCA1 Protein | 2 | 2018 | 1042 | 0.130 |
Why?
|
| Microfluidics | 1 | 2020 | 623 | 0.130 |
Why?
|
| Heme | 1 | 2016 | 291 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2022 | 2975 | 0.130 |
Why?
|
| Blood Donors | 1 | 2016 | 356 | 0.130 |
Why?
|
| Germ Cells | 1 | 2018 | 588 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2002 | 2734 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2002 | 2006 | 0.130 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2013 | 7 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2019 | 1691 | 0.120 |
Why?
|
| Arteriovenous Fistula | 1 | 2017 | 298 | 0.120 |
Why?
|
| Pancreas | 2 | 2013 | 1684 | 0.120 |
Why?
|
| Autophagy | 1 | 2022 | 1311 | 0.120 |
Why?
|
| Receptors, Fc | 1 | 2017 | 560 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2018 | 989 | 0.120 |
Why?
|
| Middle Aged | 17 | 2022 | 214639 | 0.120 |
Why?
|
| Homozygote | 1 | 2018 | 1852 | 0.120 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 414 | 0.120 |
Why?
|
| HeLa Cells | 3 | 2015 | 3211 | 0.120 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 356 | 0.120 |
Why?
|
| Protein Binding | 3 | 2012 | 9555 | 0.110 |
Why?
|
| DNA Mutational Analysis | 5 | 2017 | 4285 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1124 | 0.110 |
Why?
|
| Cell Line | 6 | 2021 | 16559 | 0.110 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2013 | 104 | 0.110 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 2720 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2017 | 716 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2009 | 619 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2017 | 5450 | 0.100 |
Why?
|
| Caregivers | 1 | 2022 | 1925 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2011 | 227 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 3569 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 2015 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8888 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1602 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2222 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2014 | 645 | 0.090 |
Why?
|
| Mitomycin | 2 | 2018 | 248 | 0.090 |
Why?
|
| Transfection | 2 | 2012 | 6081 | 0.090 |
Why?
|
| Alleles | 3 | 2022 | 7095 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 448 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2017 | 1925 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 985 | 0.090 |
Why?
|
| Bone Marrow Examination | 1 | 2009 | 165 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2020 | 72448 | 0.090 |
Why?
|
| Exons | 1 | 2015 | 2463 | 0.090 |
Why?
|
| Disease Progression | 2 | 2019 | 13219 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6476 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3843 | 0.080 |
Why?
|
| Survival Rate | 2 | 2020 | 13209 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2019 | 2474 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 1894 | 0.080 |
Why?
|
| Models, Biological | 4 | 2014 | 9810 | 0.080 |
Why?
|
| Lymphatic Vessels | 1 | 2011 | 329 | 0.080 |
Why?
|
| Fanconi Anemia Complementation Group G Protein | 1 | 2007 | 17 | 0.080 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2007 | 19 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4294 | 0.080 |
Why?
|
| Chromosome Breakage | 2 | 2011 | 171 | 0.080 |
Why?
|
| Antigens, CD34 | 2 | 2020 | 663 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2022 | 40040 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2012 | 995 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3959 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 18583 | 0.080 |
Why?
|
| Proteomics | 1 | 2020 | 3252 | 0.080 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2007 | 116 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 3670 | 0.080 |
Why?
|
| Dactinomycin | 1 | 2007 | 324 | 0.080 |
Why?
|
| Anemia | 1 | 2016 | 1421 | 0.080 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 2715 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2016 | 14154 | 0.080 |
Why?
|
| Animals | 15 | 2022 | 169173 | 0.070 |
Why?
|
| Endopeptidases | 1 | 2010 | 779 | 0.070 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2009 | 225 | 0.070 |
Why?
|
| Genes, Recessive | 1 | 2009 | 659 | 0.070 |
Why?
|
| Decision Making | 1 | 2020 | 3843 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2021 | 6659 | 0.070 |
Why?
|
| DNA Damage | 4 | 2020 | 2429 | 0.070 |
Why?
|
| Risk | 1 | 2019 | 9813 | 0.070 |
Why?
|
| Lymphedema | 1 | 2011 | 424 | 0.070 |
Why?
|
| HLA Antigens | 2 | 2022 | 1545 | 0.070 |
Why?
|
| Aged | 10 | 2021 | 162392 | 0.070 |
Why?
|
| Pancreatitis, Chronic | 1 | 2008 | 259 | 0.070 |
Why?
|
| Memory | 1 | 1995 | 2140 | 0.070 |
Why?
|
| Transplantation, Homologous | 2 | 2017 | 4830 | 0.070 |
Why?
|
| Pregnancy | 4 | 2017 | 27362 | 0.070 |
Why?
|
| Gene Expression | 1 | 2019 | 7944 | 0.070 |
Why?
|
| Family | 1 | 2016 | 3092 | 0.070 |
Why?
|
| Prefrontal Cortex | 1 | 1995 | 2044 | 0.070 |
Why?
|
| Genetic Counseling | 1 | 2009 | 579 | 0.070 |
Why?
|
| Erythropoiesis | 2 | 2016 | 702 | 0.070 |
Why?
|
| Cell Line, Transformed | 2 | 2007 | 977 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4272 | 0.070 |
Why?
|
| Interphase | 1 | 2005 | 251 | 0.070 |
Why?
|
| Ubiquitin | 2 | 2016 | 825 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2019 | 23705 | 0.070 |
Why?
|
| Vidarabine | 2 | 2017 | 348 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2009 | 801 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 6803 | 0.060 |
Why?
|
| RNA | 2 | 2017 | 2607 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 1994 | 0.060 |
Why?
|
| Cytoplasm | 2 | 2008 | 1625 | 0.060 |
Why?
|
| Consensus | 2 | 2022 | 2744 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7445 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2003 | 160 | 0.060 |
Why?
|
| Cell Differentiation | 5 | 2020 | 11644 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2020 | 10600 | 0.060 |
Why?
|
| Mass Screening | 1 | 2019 | 5219 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2021 | 3719 | 0.060 |
Why?
|
| Physical Examination | 1 | 2009 | 1239 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3800 | 0.060 |
Why?
|
| Tetraploidy | 1 | 2021 | 28 | 0.060 |
Why?
|
| Echocardiography | 1 | 2015 | 5045 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2002 | 142 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1358 | 0.050 |
Why?
|
| Registries | 2 | 2017 | 8042 | 0.050 |
Why?
|
| Mosaicism | 1 | 2004 | 446 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5190 | 0.050 |
Why?
|
| Pluripotent Stem Cells | 1 | 2008 | 792 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2008 | 2990 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 1378 | 0.050 |
Why?
|
| HLA-B Antigens | 1 | 2022 | 383 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 4748 | 0.050 |
Why?
|
| Androgens | 1 | 2009 | 1231 | 0.050 |
Why?
|
| Mice | 8 | 2022 | 80270 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1156 | 0.050 |
Why?
|
| Genes, BRCA1 | 1 | 2004 | 759 | 0.050 |
Why?
|
| Genes, BRCA2 | 1 | 2003 | 591 | 0.050 |
Why?
|
| Chromosomes, Human | 1 | 2002 | 474 | 0.050 |
Why?
|
| Apoptosis | 1 | 2017 | 9960 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 2937 | 0.050 |
Why?
|
| Growth Differentiation Factors | 1 | 2020 | 92 | 0.050 |
Why?
|
| Retroviridae | 1 | 2002 | 954 | 0.050 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 386 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 9730 | 0.040 |
Why?
|
| Protein Transport | 1 | 2005 | 2051 | 0.040 |
Why?
|
| Fetal Hemoglobin | 1 | 2021 | 333 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2002 | 2089 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2021 | 21804 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2022 | 1264 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2002 | 744 | 0.040 |
Why?
|
| Zebrafish | 2 | 2022 | 2998 | 0.040 |
Why?
|
| Pyrococcus horikoshii | 1 | 2017 | 5 | 0.040 |
Why?
|
| Lactation Disorders | 1 | 2017 | 17 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 20066 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2017 | 62039 | 0.040 |
Why?
|
| Galactose | 1 | 2019 | 311 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 2983 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2008 | 1510 | 0.040 |
Why?
|
| Mutagens | 2 | 2011 | 176 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 551 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 23482 | 0.040 |
Why?
|
| Virulence | 1 | 2021 | 1337 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2005 | 2985 | 0.040 |
Why?
|
| World Health Organization | 1 | 2022 | 1287 | 0.040 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2016 | 99 | 0.040 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 184 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2017 | 605 | 0.040 |
Why?
|
| Penetrance | 1 | 2017 | 360 | 0.040 |
Why?
|
| Monocytes | 2 | 2019 | 2627 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1395 | 0.040 |
Why?
|
| Informed Consent | 1 | 2022 | 963 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 1412 | 0.040 |
Why?
|
| Cell Survival | 2 | 2020 | 6028 | 0.040 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2016 | 195 | 0.040 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 386 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 1997 | 381 | 0.030 |
Why?
|
| Fetal Death | 1 | 2017 | 456 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 833 | 0.030 |
Why?
|
| Liver | 1 | 2011 | 7588 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2016 | 313 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2806 | 0.030 |
Why?
|
| Erythroid Cells | 1 | 2016 | 249 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 724 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 2016 | 242 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 726 | 0.030 |
Why?
|
| United States | 2 | 2019 | 67895 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 177 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2016 | 675 | 0.030 |
Why?
|
| Myeloablative Agonists | 1 | 2014 | 225 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2014 | 228 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 2017 | 473 | 0.030 |
Why?
|
| Perfusion | 1 | 2017 | 1270 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7877 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 3525 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 1647 | 0.030 |
Why?
|
| Acute Disease | 1 | 2022 | 7137 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2971 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2017 | 763 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2645 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2008 | 4978 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2014 | 710 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 13215 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 4903 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2022 | 3124 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2016 | 2507 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2011 | 185 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 617 | 0.020 |
Why?
|
| Memory Disorders | 1 | 1997 | 1141 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2019 | 2589 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 2936 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2017 | 4028 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 410 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1997 | 1648 | 0.020 |
Why?
|
| Mitosis | 1 | 2014 | 1247 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2013 | 784 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 58293 | 0.020 |
Why?
|
| Age of Onset | 1 | 2015 | 3312 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2010 | 261 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2095 | 0.020 |
Why?
|
| Calibration | 1 | 2011 | 797 | 0.020 |
Why?
|
| Leukocytes | 1 | 2017 | 2092 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2013 | 664 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2031 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4887 | 0.020 |
Why?
|
| Methotrexate | 1 | 2014 | 1726 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8079 | 0.020 |
Why?
|
| Graft Survival | 1 | 2017 | 3753 | 0.020 |
Why?
|
| Learning | 1 | 1995 | 1603 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 4035 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 7983 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 7015 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1878 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 6092 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 2034 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 1386 | 0.020 |
Why?
|
| DNA | 1 | 2018 | 7084 | 0.020 |
Why?
|
| Sepsis | 1 | 2017 | 2463 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2008 | 537 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 34429 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4635 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 696 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15900 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9028 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2011 | 22636 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 2810 | 0.010 |
Why?
|
| Iron | 1 | 2011 | 1736 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 12285 | 0.010 |
Why?
|
| Brain Stem Neoplasms | 1 | 2003 | 200 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 2003 | 340 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 16726 | 0.010 |
Why?
|
| RNA Interference | 1 | 2010 | 2975 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 3683 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9838 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2008 | 2104 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3585 | 0.010 |
Why?
|
| Medulloblastoma | 1 | 2003 | 721 | 0.010 |
Why?
|
| Lung | 1 | 2017 | 9734 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2008 | 4223 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2011 | 6121 | 0.010 |
Why?
|
| Language Tests | 1 | 1997 | 188 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11664 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 15606 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 8996 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19529 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 15040 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 13761 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 51354 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2003 | 4015 | 0.000 |
Why?
|
| Neuropsychological Tests | 1 | 1997 | 6868 | 0.000 |
Why?
|